Conmorbilidades asociadas al virus de Epstein – Barr: variables sociodemográficas y diagnóstico de laboratorio en la población
DOI:
https://doi.org/10.56048/MQR20225.8.1.2024.4560-4591Palabras clave:
Infección; comorbilidades; diagnóstico de laboratorio; adultos; poblaciónResumen
El objetivo de esta investigación fue: analizar las comorbilidades asociadas al virus de Epstein-Barr en la población, centrándose en la comprensión de las variables sociodemográficas y los métodos de diagnóstico de laboratorio. Pues, el virus de Epstein-Barr (VEB), miembro de la familia de los herpesvirus, constituye una infección viral ubicua en la población humana. Su presencia se extiende ampliamente por todo el mundo, afectando a personas de diferentes edades y regiones geográficas. Para ello, se implementó una metodología documental de tipo descriptiva, aplicando diferentes criterios de elegibilidad. Se realizó una revisión bibliográfica utilizando diversas bases de datos científicas como PubMed, SciELO, Lilacs, Science Direct, Google Scholar y Redalyc, así como informes de salud. Las ecuaciones de búsqueda incluyeron términos como "enfermedad linfoproliferativa", "virus de Epstein-Barr", "variables sociodemográficas" y "diagnóstico de laboratorio", combinados mediante operadores booleanos como 'AND', 'OR' y 'NOT'. En donde se eligieron un total de 20 artículos. Los resultados revelaron que las variables sociodemográficas existentes en este virus son la edad particularmente en adultos > de 20 años, de género masculino. El lo que respecta a las pruebas clínicas y de laboratorio destacan técnicas como la carga de ADN-VEB en muestras de sangre, la ADNemia del VEB.
Descargas
Métricas
Cited
DOI: 10.56048
Citas
Wang Z. La superioridad del ADN del virus de Epstein-Barr en plasma sobre células mononucleares de sangre periférica para el seguimiento de enfermedades linfoproliferativas de células NK positivas para EBV. Hematol Oncol. 2022;40(3):381–93.
Lindsay J, Yong MK, Greenwood M, Kong DCM, Chen SCA, Rawlinson W, et al. Epstein‐Barrvirus related post‐transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation. Rev Med Virol [Internet]. 2020 Jul 17;30(4):2108. Available from: https://onlinelibrary.wiley.com/doi/10.1002/rmv.2108
Chapman J. Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders. Surg Pathol Clin [Internet]. 2023 Jun;16(2):213–31. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1875918123000089
Kim EK, Yang WI, Ryu HJ, Ji HL, Yoon SO. Practical Approach to the Histologic Diagnosis of Gastrointestinal Lymphomas Through the First-line Marker Battery of CD20, CD3, CD30, and Epstein-Barr Virus–encoded RNAs. Adv Anat Pathol [Internet]. 2020 Mar;27(2):75–86. Available from: https://journals.lww.com/10.1097/PAP.0000000000000260
Leal J, Rincón M, Ortega P, Echeverría M. Infección Por El Virus De Epstein-Barr E Interleucina 10 Sérica En Niños. Enfermería Investig [Internet]. 2023;8(1):27–35. Available from: 10.31243/ei.uta.v8i1.1881.2023
Petrara MR, Serraino D, Di Bella C, Neri F, Del Bianco P, Brutti M, et al. Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors. Cancer Lett [Internet]. 2020 Jan;469:323–31. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0304383519305488
Mariano J, Álvarez MR, Sabbione M, Juana ML, Yaniunas E, Gómez MN. Todo sobre una entidad poco conocida: el síndrome linfoproliferativo postrasplante. Rev Argentina Radiol / Argentinian J Radiol [Internet]. 2023 Jun 30;87(2):54–65. Available from: https://www.revistarar.com/frame_esp.php?id=81
Toro A. Virus de Epstein-Barr: más que una mononucleosis infecciosa. Med y Lab [Internet]. 2023 Jan 3;27(1):51–64. Available from: https://medicinaylaboratorio.com/index.php/myl/article/view/621
Pagliuca S, Bommier C, Michonneau D, Meignin V, Salmona M, Robin M, et al. Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant [Internet]. 2019 Dec;25(12):2490–500. Available from: https://doi.org/10.1016/j.bbmt.2019.08.006
Chen HS, Ho MC, Hu RH, Wu JF, Chen HL, Ni YH, et al. Roles of Epstein–Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation. J Formos Med Assoc [Internet]. 2019 Sep;118(9):1362–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0929664618302390
Hyun H, Park E, Cho M, Min SI, Ha J, Kang HJ, et al. Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia. J Korean Med Sci [Internet]. 2019;34(30):1–13. Available from: https://jkms.org/DOIx.php?id=10.3346/jkms.2019.34.e203
Kim SJ, Hyeon J, Cho I, Ko YH, Kim WS. Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas. Cancer Res Treat [Internet]. 2019 Apr 15;51(2):611–22. Available from: http://e-crt.org/journal/view.php?doi=10.4143/crt.2018.191
Salmona M, Stefic K, Mahjoub N, de Fontbrune FS, Maylin S, Simon F, et al. Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring. Virol J [Internet]. 2020 Dec 3;17(1):20. Available from: https://virologyj.biomedcentral.com/articles/10.1186/s12985-020-1285-7
Beltran BE, Castro D, Paredes S, Miranda RN, Castillo JJ. EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk‐stratification and management. Am J Hematol [Internet]. 2020 Apr 29;95(4):435–45. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ajh.25760
Moreno M. Características sociodemográficas, clínicas y desenlace de pacientes pediátricos con infección por Virus del Epstein Barr. Sustain [Internet]. 2020;14(2):1–4. Available from: http://www.unpcdc.org/media/15782/sustainable procurement practice.pdf%0Ahttps://europa.eu/capacity4dev/unep/document/briefing-note-sustainable-public-procurement%0Ahttp://www.hpw.qld.gov.au/SiteCollectionDocuments/ProcurementGuideIntegratingSustainabilit
Luo H, Liu D, Liu W, Jin J, Bi X, Zhang P, et al. Clinical and genetic characterization of Epstein-Barr virus–associated T/NK-cell lymphoproliferative diseases. J Allergy Clin Immunol [Internet]. 2023 Apr;151(4):1096–109. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0091674922015706
Preikasaitis J, Allen U, Bollard C, Dharnidharka V, Dulek D, Verde M, et al. La Conferencia de Consenso de IPTA Nashville sobre trastornos linfoproliferativos postrasplante después del trasplante de órganos sólidos en niños: III - Directrices de consenso para la carga del virus de Epstein-Barr y el seguimiento de otros biomarcador. Traspante de pediatra. 2023;2(1):126–9.
Warley F, Jauk F, Otero V, Rivello HG. Single-center “Argentine” analysis of post-transplant lymphoproliferative disorders: incidence, histopathological characteristics and EBV status. Hematol Transfus Cell Ther [Internet]. 2023 Jul;45:S119–25. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2531137922014006
Fuentes J, Valero N. Inmunidad y factores de riesgo al virus epstein barr en adultos. Rev Científica FIPCAEC [Internet]. 2022;7(4):1516–25. Available from: https://fipcaec.com/index.php/fipcaec/article/view/696/1239
Veloz A. Vol. 4, Universidad Central del Ecuador. 2023. p. 88–100 Epstein Barr Virus detectado por inmunohistoquímica, en muestras de linfomas diagnosticados en pacientes del Hospital Pediátrico Baca Ortiz, Quito DM, enero 2016 – diciembre 2022. Available from: https://www.dspace.uce.edu.ec/server/api/core/bitstreams/08c90326-8ca0-48c3-a420-f6a5deeadf5c/content
Naula J, Reibán E. Enfermedad de Castleman multicéntrica. J Sci [Internet]. 2023;7(3):3379–97. Available from: https://www.investigarmqr.com/ojs/index.php/mqr/article/view/623/2472
Kuno M, Ito A, Maeshima AM, Taniguchi H, Tanaka T, Inamoto Y, et al. T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Int J Hematol [Internet]. 2020 Aug 29;112(2):193–9. Available from: https://link.springer.com/10.1007/s12185-020-02890-1
Coello K, Valero N. Características clínicas y de laboratorio en pacientes pediátricos con infección por Epstein-Bar. Rev Polo del Conoc. 2023;8(4):26–8.
Bommier C, Michonneau D, Meignin V, Salmona M, Robin M, Prata PH, et al. Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant [Internet]. 2019 Dec;25(12):2490–500. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1083879119305208
Nambiar R, Shaw K, Curry PS. Normas Vancouver. J Microbiol Methods [Internet]. 2017;141:60–2. Available from: bibliotecahcam.iess.gob.ec/opac-tmpl/hcam/pages/vancouver.pdf%0Ahttps://www.aeesme.org/wp-content/uploads/2021/02/Normas-Vancouver.pdf
Alvarado V. Manejo de normas de bioseguridad del personal de enfermería. 2014;(c).
Hu J, Yu YW, Han DS, Li XJ, Zhang YQ, Cai HL, et al. Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient. Front Immunol [Internet]. 2023 Sep 15;14(5):1–9. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1244534/full
Shi J, Chu C, Yu M, Zhang D, Li Y, Fan Y, et al. Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus. Ital J Pediatr [Internet]. 2021 Dec 7;47(1):3. Available from: https://ijponline.biomedcentral.com/articles/10.1186/s13052-020-00949-7
Ogawa K, Honjo M, Sakamoto K, Funamizu N, Tamura K, Shine M, et al. Epstein–Barr Virus–Associated Latent Malignant Lymphoma With Acute Exacerbation After Living Donor Liver Transplantation: Case Report. Transplant Proc [Internet]. 2023 Oct;55(8):1959–63. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0041134523004748
Chadburn A. Post-transplant lymphoproliferative disorders (PTLD) in adolescents and young adults: A category in need of definition. Semin Diagn Pathol [Internet]. 2023 Nov;40(6):401–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0740257023000801
Penzhorn IH, Schneider JW, Sher-Locketz C. The Prevalence of Epstein-Barr Virus in Plasma Cell Neoplasms is Higher in HIV-Positive Individuals. Int J Surg Pathol [Internet]. 2023 Aug 1;31(5):564–71. Available from: http://journals.sagepub.com/doi/10.1177/10668969221113490
Chen J, Sun Y, Xu L, Xiaohi Z, Liu K. El valor predictivo de la monitorización de la carga de ADN del virus de Epstein-Barr en plasma para enfermedades linfoproliferativas después del trasplante de células madre hematopoyéticas haploides. Zhonghua Xue Ye Xue Za Zhi [Internet]. 2023;44(4):284–8. Available from: https://pesquisa.bvsalud.org/portal/resource/es/mdl-37356996
Tanaka A, Kawaguchi T, Imadome K, Hara S. Trastornos linfoproliferativos asociados al virus de Epstein-Barr después de la vacunación COVID-19 con ARNm de BNT162b2. Rev Jpn. 2023;64(4):277–82.
Lupo J, Germi R, Lancar R, Algarte-Genin M, Hendel-Chavez H, Taoufik Y, et al. Epstein–Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era. AIDS [Internet]. 2019 May 1;33(6):993–1000. Available from: https://journals.lww.com/00002030-201905010-00007
Nakid C, Choquet S, Gauthier N, Balegroune N, Tarantino N, Morel V, et al. Distinct immunopathological mechanisms of EBV-positive and EBV-negative posttransplant lymphoproliferative disorders. Am J Transplant [Internet]. 2021 Aug;21(8):2846–63. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1600613522086828
Medeiros LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, Vega F, Feldman AL, et al. Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship. Mod Pathol [Internet]. 2021 Dec;34(12):2154–67. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0893395222003763
Ordoñez J, Mejía M, Tamayo M, Infante Gómez A. Hydroa vacciniforme-like lymphoproliferative disorder (HV-LPD) is an Epstein-Barr virus (EBV) associated disease. An Bras Dermatol [Internet]. 2021 May;96(3):388–90. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0365059621000775
Dutta R, Miao SY, Phan P, Fernandez-Pol S, Shiraz P, Ho D, et al. Epstein–Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report. J Med Case Rep [Internet]. 2021 Dec 28;15(1):170. Available from: https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-021-02744-2
Miyagi S, Ishikawa E, Nakamura M, Shimada K, Yamamura T, Furukawa K, et al. Reappraisal of Primary Epstein-Barr Virus (EBV)-positive Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract. Am J Surg Pathol [Internet]. 2020 Sep;44(9):1173–83. Available from: https://journals.lww.com/10.1097/PAS.0000000000001499
Isobe Y. Epstein-Barr virus infection and lymphoproliferative disorders. Rinsho Ketsueki. 2020;61(9):1286–96.
Ma Y, Bao Y, Zheng M. Epstein–Barr virus-associated B-cell lymphoproliferative disorder meeting the definition of CAEBV B cell disease: a case report. BMC Infect Dis [Internet]. 2023 Jul 7;23(1):453. Available from: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08430-6
Seo E, Kim J, Oh SH, Kim KM, Kim DY, Lee J. Epstein‐Barr viral load monitoring for diagnosing post‐transplant lymphoproliferative disorder in pediatric liver transplant recipients. Pediatr Transplant [Internet]. 2020 Jun 17;24(4). Available from: https://onlinelibrary.wiley.com/doi/10.1111/petr.13666
Inoue H, Rai S, Tanaka H, Espinoza JL, Komori-Inoue M, Kakutani H, et al. Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy. Viruses [Internet]. 2020 Apr 8;12(4):416. Available from: https://www.mdpi.com/1999-4915/12/4/416
Li Z, Wang X, Jing F, Zhou J, Han Y. Analysis of two laboratory tests for determination of EBV‐IM in children. J Med Virol [Internet]. 2022 Jun 14;94(6):2747–54. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jmv.27490
Baker A, Frauca Remacha E, Torres Canizales J, Bravo-Gallego LY, Fitzpatrick E, Alonso Melgar A, et al. Current Practices on Diagnosis, Prevention and Treatment of Post-Transplant Lymphoproliferative Disorder in Pediatric Patients after Solid Organ Transplantation: Results of ERN TransplantChild Healthcare Working Group Survey. Children [Internet]. 2021 Jul 29;8(8):661. Available from: https://www.mdpi.com/2227-9067/8/8/661
Zhong Y, Huang CH, Soe WM, Chan KW, Isa MS, Soh J, et al. A Novel X-Linked Inhibitor of Apoptosis Deficient Variant Showing Attenuated Epstein-Barr Virus Response. J Pediatric Infect Dis Soc [Internet]. 2021 Apr 3;10(3):345–8. Available from: https://academic.oup.com/jpids/article/10/3/345/5843690
Gamaleldin MA, Ghallab OM, Nadwan EA, Abo Elwafa RA. PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia. Clin Transl Oncol [Internet]. 2021 Nov 13;23(11):2309–22. Available from: https://link.springer.com/10.1007/s12094-021-02657-y
Satou A, Nakamura S. EBV‐positive B‐cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency. Cancer Med [Internet]. 2021 Oct 13;10(19):6777–85. Available from: https://onlinelibrary.wiley.com/doi/10.1002/cam4.4198
Sundram U. Cutaneous Lymphoproliferative Disorders: What’s New in the Revised 4th Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms. Adv Anat Pathol [Internet]. 2019 Mar;26(2):93–113. Available from: https://journals.lww.com/00125480-201903000-00003
Kim JH, Cho H, Sung H, Jung AR, Lee YS, Lee S wook, et al. Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders–diffuse large B-cell lymphoma. Sci Rep [Internet]. 2021 Feb 3;11(1):2880. Available from: https://www.nature.com/articles/s41598-021-82534-4
İmren IG, Demirkan N, Çomut E, Duygulu Ş. Epstein‐Barr virus‐associated hydroa vacciniforme‐like lymphoproliferative syndrome: excellent response to antiviral therapy. Int J Dermatol [Internet]. 2020 Dec 17;59(12). Available from: https://onlinelibrary.wiley.com/doi/10.1111/ijd.15141
Stanjek A, Łaszewska A, Zawadzki F, Kobylska A, Urlik M, Stącel T, et al. Diagnostics of the Epstein-Barr Virus Before and After Lung Transplantation in a Patient With Developing Posttransplant Lymphoproliferative Disease: A Case Report. Transplant Proc [Internet]. 2022 May;54(4):1180–2. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0041134522002044
Quintero Bernabeu J, Juamperez J, Mercadal‐Hally M, Larrarte King M, Gallego Melcon S, Gros Subias L, et al. Epstein–Barr virus‐associated risk factors for post‐transplant lymphoproliferative disease in pediatric liver transplant recipients. Pediatr Transplant [Internet]. 2022 Sep 24;26(6):14292. Available from: https://onlinelibrary.wiley.com/doi/10.1111/petr.14292
Fujimoto M, Takai T, Okada M, Okuno A, Haga H. Systemic EBV-Positive Methotrexate-Related Lymphoproliferative Disorder Associated With Skin Lesion Resembling EBV-Positive Mucocutaneous Ulcer: A Report of Two Cases. Am J Dermatopathol [Internet]. 2021 Aug;43(8):604–5. Available from: https://journals.lww.com/10.1097/DAD.0000000000001930
Kadoba K, Nishimura K, Uchino K, Waki D, Murabe H, Yokota T. Age-related Epstein-Barr Virus-associated Lymphoproliferative Disorder Masquerading as Systemic Lupus Erythematosus. Intern Med [Internet]. 2021 Aug 1;60(15):6702–20. Available from: https://www.jstage.jst.go.jp/article/internalmedicine/60/15/60_6702-20/_article
Miao S, Phan P, Fernandez S, Shiraz P, Ho D, Mannis G, et al. Epstein–Barr as pulmonary disease in a patient with acute myeloid leukemia: a case report. J Med Case Rep [Internet]. 2021 Dec 28;15(1):170. Available from: https://jmedicalcasereports.biomedcentral.com/articles/10.1186/s13256-021-02744-2
Kaieda S, Koga T, Yamada K, Ida H. Epstein-Barr Virus–Related Lymphoproliferative Disorders–Associated Polymyositis in a Patient With Rheumatoid Arthritis. JCR J Clin Rheumatol [Internet]. 2021 Dec;27(8S):S781–2. Available from: https://journals.lww.com/10.1097/RHU.0000000000001487
Yamamoto M, Shindo M, Funayama T, Sumi C, Saito T, Toki Y, et al. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection. Medicine (Baltimore) [Internet]. 2022 Mar 25;101(12):29055. Available from: https://journals.lww.com/10.1097/MD.0000000000029055
Wang K, Li J, Zhou X, Lv J, Wang Y, Li X. Case Report: Primary Indolent Epstein-Barr Virus-Positive T-Cell Lymphoproliferative Disease Involving the Central Nervous System. Front Surg [Internet]. 2022 Mar 2;9. Available from: https://www.frontiersin.org/articles/10.3389/fsurg.2022.775185/full
Abdulovski R, Møller DL, Knudsen AD, Sørensen SS, Rasmussen A, Nielsen SD, et al. Early‐ and late‐onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients. Eur J Haematol [Internet]. 2022 Oct 14;109(4):343–50. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ejh.13815
Kitamura N, Sugiyama K, Nagasawa Y, Hamaguchi M, Kobayashi H, Takei M. Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis. Clin Exp Rheumatol [Internet]. 2021 Feb 26;40(7):1330–5. Available from: https://www.clinexprheumatol.org/abstract.asp?a=17140
Balaguer-Rosello A, Piñana JL, Bataller L, Montoro J, Romero S, Navarro I, et al. Central Nervous System Involvement in Epstein–Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther [Internet]. 2021 Mar;27(3):261.e1-261.e7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2666636720300932
Tsutsumi Y, Kitano S, Yanagita S, Tachibana M. Epstein-Barr virus-positive mucocutaneous ulcer, plasmablastic type, associated with nodal CD4+ angioimmunoblastic T-cell lymphoma and generalised pruritus: a self-limiting lymphoproliferative disorder resembling cutaneous plasmablastic lymphoma. BMJ Case Rep [Internet]. 2022 May 6;15(5):e247430. Available from: https://casereports.bmj.com/lookup/doi/10.1136/bcr-2021-247430
Perry A., Smith L., Bagg A. Classic Hodgkin Lymphoma – Old Disease, New Directions: An Update on Pathology, Molecular Features and Biological Prognostic Markers. Acta Med Acad [Internet]. 2021 May 26;50(1):110. Available from: http://www.ama.ba/index.php/ama/article/view/448
Publicado
Cómo citar
Número
Sección
Categorías
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
®
Los autores se comprometen a respetar la información académica de otros autores, y a ceder los derechos de autor a la Revista MQRInvestigar, para que el artículo pueda ser editado, publicado y distribuido. El contenido de los artículos científicos y de las publicaciones que aparecen en la revista es responsabilidad exclusiva de sus autores. La distribución de los artículos publicados se realiza bajo una licencia 
